Japan's takeda aims to grow in spain
Catalan Economy
01 Mar 2010
Japanese pharmaceutical company takeda aims at strengthening its position in spain with the creation of a new subsidiary in barcelona. the japanese group will initially market its drugs for hypertension and diabetes. in the coming months, takeda also plans to launch a new treatment for osteosarcoma, which will represent a significant development in the field of cancer treatments in spain.
takeda is the largest pharmaceutical company in japan and one of the world's 20 largest pharmaceutical companies. its european operations include germany, switzerland, austria, france, britain, italy and spain. catalan agency acc1ó and its invest in catalonia unit offered advise throughout the operation.
source: la vanguardia 25/02/2010
Related News and Success stories.
-
29 Oct 2025
See more Catalonia sets new strategy to attract €6 billion in foreign investment by 2030Catalonia sets new strategy to attract €6 billion in foreign investment by 2030
-
27 Oct 2025
See more Catalonia strengthens business ties with China in Industry 4.0 technologiesCatalonia strengthens business ties with China in Industry 4.0 technologies
-
26 Oct 2025
See more Chinese investment in Catalonia triples compared to the previous five-year periodChinese investment in Catalonia triples compared to the previous five-year period
-
23 Oct 2025
See more US company Elian to invest over €200 million to expand its plant-based protein facility in BarcelonaUS company Elian to invest over €200 million to expand its plant-based protein facility in Barcelona